已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Longitudinal radiological follow-up of individual level non-ischemic cerebral enhancing lesions following endovascular aneurysm treatment

医学 血管内治疗 动脉瘤 放射科 放射性武器 外科
作者
Zakaria Guetarni,R Bernard,Grégoire Boulouis,Marc‐Antoine Labeyrie,Alessandra Biondi,Stéphane Velasco,Guillaume Saliou,Bruno Bartolini,Benjamin Daumas-Duport,Romain Bourcier,Kévin Janot,Denis Herbreteau,Caterina Michelozzi,Kévin Premat,Hocine Redjem,Simon Escalard,Nicolas Bricout,Pierre Thouant,Charles Artéaga,Laurent Pierot
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:16 (8): 838-845 被引量:5
标识
DOI:10.1136/jnis-2023-020060
摘要

Background Non-ischemic cerebral enhancing (NICE) lesions following aneurysm endovascular therapy are exceptionally rare, with unknown longitudinal evolution. Objective To evaluate the radiological behavior of individual NICE lesions over time. Methods Patients included in a retrospective national multicentric inception cohort were analyzed. NICE lesions were defined, using MRI, as delayed onset punctate, nodular, or annular foci enhancements with peri-lesion edema, distributed in the vascular territory of the aneurysm treatment, with no other confounding disease. Lesion burden and the longitudinal behavior of individual lesions were assessed. Results Twenty-two patients were included, with a median initial lesion burden of 36 (IQR 17–54) on the first MRI scan. Of the 22 patients with at least one follow-up MRI scan, 16 (73%) had new lesions occurring mainly within the first 200 weeks after the date of the procedure. The median number of new lesions per MRI was 6 (IQR 2–16). Among the same 22 patients, 7 (32%) had recurrent lesions. The median persistent enhancement of a NICE lesion was 13 weeks (IQR 6–30). No factor was predictive of early regression of enhancement activity with lesion regression kinetics mainly being patient-dependent. Conclusions The behavior of individual NICE lesions was found to be highly variable with an overall patient-dependent regression velocity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
汉堡包应助科研通管家采纳,获得10
1秒前
1秒前
思源应助科研通管家采纳,获得10
1秒前
1秒前
小二郎应助科研通管家采纳,获得10
1秒前
脑洞疼应助科研通管家采纳,获得10
1秒前
FashionBoy应助科研通管家采纳,获得30
1秒前
脑洞疼应助科研通管家采纳,获得10
1秒前
RJ应助科研通管家采纳,获得10
1秒前
共享精神应助科研通管家采纳,获得10
1秒前
1秒前
2秒前
dark_zone发布了新的文献求助10
2秒前
Lucas应助WUHUDASM采纳,获得10
3秒前
4秒前
在水一方应助Joseph_LIN采纳,获得10
5秒前
小怪兽完成签到 ,获得积分10
5秒前
咩夸发布了新的文献求助10
7秒前
7秒前
小禾完成签到 ,获得积分10
8秒前
9秒前
9秒前
旋光活性完成签到 ,获得积分10
9秒前
9秒前
9秒前
10秒前
红豆盖饭发布了新的文献求助10
10秒前
10秒前
kyo发布了新的文献求助10
10秒前
天天快乐应助阳光萌萌采纳,获得10
11秒前
小蘑菇应助咩夸采纳,获得10
12秒前
12秒前
gyh应助机灵柚子采纳,获得30
13秒前
光而不耀发布了新的文献求助10
13秒前
lj发布了新的文献求助10
13秒前
eclo完成签到 ,获得积分10
15秒前
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Wearable Exoskeleton Systems, 2nd Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6057797
求助须知:如何正确求助?哪些是违规求助? 7890594
关于积分的说明 16295429
捐赠科研通 5202857
什么是DOI,文献DOI怎么找? 2783696
邀请新用户注册赠送积分活动 1766386
关于科研通互助平台的介绍 1647012